Q2 2011

Filed Dec 9, 2010 · 10-Q · 39 days after period end · 0001193125-10-277485

Q2 2011 · 10-Q

Revenue

$27.13K

no prior Q2 2010 on file

Net Income

$2.05M

no prior Q2 2010 on file

EPS Diluted

-$0.09

no prior Q2 2010 on file

Gross Profit$27,126—

Operating Income

Same quarter

no prior Q2 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Oct 31, 2010 · filed Dec 9, 2010 · 39 d after period end

Tenax Therapeutics, Inc. · CIK 34956 · Engraved from SEC EDGAR